Evidence map›Paper›PMID 37264043›Full record

ArticleScientific reports2023

Simultaneous imaging of ultrasonic relative backscatter and attenuation coefficients for quantitative liver steatosis assessment.

José Timaná, Hector Chahuara, Lokesh Basavarajappa, Adrian Basarab, Kenneth Hoyt, Roberto Lavarello

Abstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

José Timaná *Laboratorio de Imágenes Médicas, Pontificia Universidad Católica del Perú, Lima, Peru.
Hector ChahuaraLaboratorio de Imágenes Médicas, Pontificia Universidad Católica del Perú, Lima, Peru.
Lokesh BasavarajappaDepartment of Bioengineering, University of Texas at Dallas, Richardson, TX, USA.
Adrian BasarabINSA-Lyon, UCBL, CNRS, Inserm, CREATIS UMR 5220 U1294, Université de Lyon, Villeurbanne, France.
Kenneth HoytDepartment of Bioengineering, University of Texas at Dallas, Richardson, TX, USA.
Roberto Lavarello *Laboratorio de Imágenes Médicas, Pontificia Universidad Católica del Perú, Lima, Peru. lavarello.rj@pucp.edu.pe.

Funding

Multiparametric ultrasound imaging for early detection of nonalcoholic fatty liver diseaseR01DK126833 · NIDDK · UNIVERSITY OF TEXAS DALLAS · PI HOYT, KENNETH · 2021 to 2024
$1.6M
3D Super-Resolution Ultrasound Imaging for Cancer Detection and Treatment MonitoringR01EB025841 · NIBIB · UNIVERSITY OF TEXAS DALLAS · PI HOYT, KENNETH · 2019 to 2022
$1.3M
The H-scan approach to classifying ultrasound echoesR21EB025290 · NIBIB · UNIVERSITY OF ROCHESTER · PI PARKER, KEVIN J · 2018 to 2019
$420k
NIBIB NIH HHS R01 EB025841NIBIB NIH HHS R21 EB025290NIDDK NIH HHS R01 DK126833
6 · The paper itself

Abstract

Prevalence of liver disease is continuously increasing and nonalcoholic fatty liver disease (NAFLD) is the most common etiology. We present an approach to detect the progression of liver steatosis based on quantitative ultrasound (QUS) imaging. This study was performed on a group of 55 rats that were subjected to a control or methionine and choline deficient (MCD) diet known to induce NAFLD. Ultrasound (US) measurements were performed at 2 and 6 weeks. Thereafter, animals were humanely euthanized and livers excised for histological analysis. Relative backscatter and attenuation coefficients were simultaneously estimated from the US data and envelope signal-to-noise ratio was calculated to train a regression model for: (1) fat fraction percentage estimation and (2) performing classification according to Brunt's criteria in grades (0 <5%; 1, 5-33%; 2, >33-66%; 3, >66%) of liver steatosis. The trained regression model achieved an [Formula: see text] of 0.97 (p-value < 0.01) and a RMSE of 3.64. Moreover, the classification task reached an accuracy of 94.55%. Our results suggest that in vivo QUS is a promising noninvasive imaging modality for the early assessment of NAFLD.

Indexed as

Non-alcoholic Fatty Liver DiseaseAnimalsCholineLiverRatsUltrasonicsUltrasonographyCholine

Identifiers

PMID37264043
PMCPMC10235029

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.